Regulations

To ensure sound corporate governance, regulatory compliance in R&D operations, and the protection of stakeholder rights, HanchorBio has established a comprehensive set of internal management systems and standard operating procedures (SOPs). We strictly adhere to both international and Taiwan regulations and industry standards, while continuously reviewing and optimizing relevant policies based on operational needs.

Corporate Governance Regulations

Articles of Incorporation

Defines the company’s founding objectives, organizational structure, shareholder meeting operations, and the roles and responsibilities of the Board of Directors.

[Download]

Board of Directors Rules of Procedure

Specifies the Board’s authority, meeting procedures, conflict-of-interest handling, and mechanisms to enhance transparency and oversight.

[Download]

Code of Integrity Management

Declares the company’s commitment to integrity and fair competition, applicable to all employees and senior management.

[Download]

Sustainability & Information Management

[Download]

Intellectual Property Management

[Download]

Trade Secrets Management

[Download]

Employee Conduct & HR Regulations

Employee Handbook

Outlines corporate culture, workplace behavior guidelines, leave policies, compensation, and benefits.

[Download]

Policy on Prevention of Sexual Harassment and Workplace Equality

Ensures workplace safety, diversity, respect, and establishes complaint and investigation procedures.

[Download]

Insider Trading Prevention

To safeguard market fairness and protect investor rights, while upholding corporate integrity and regulatory compliance, HanchorBio has established the Insider Trading Prevention Policy. This policy governs how company insiders and related parties handle and trade material information, strictly prohibiting any insider trading activities. It explicitly stipulates that insiders, including but not limited to directors, are forbidden from trading company securities based on non-public information. In addition, the policy enforces trading restrictions during blackout periods, such as 30 days prior to the announcement of annual financial reports and 15 days prior to quarterly financial report announcements, ensuring full compliance and transparency.